Journals / Klinik Psikofarmakoloji Bülteni / 2010 / Cilt: 20 - Sayı: 4

Sertralin kullanımına bağlı ekimoz: Bir olgu sunumu

Ecchymosis due to sertraline use: A case report

Pages
321–323
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This report includes a case which presented to an emergency department with a large ecchymotic lesion on the left flank due to sertraline use and a review of the relevant literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Sertraline is a widely used antidepressant due to its low adverse effect profile.
📊
Key Findings & Data:Hematological adverse effects related to sertraline are uncommon.
💡
Conclusion & Impact:This report includes a case which presented to an emergency department with a large ecchymotic lesion on the left flank due to sertraline use and a review of the relevant literature.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Sertraline is a widely used antidepressant due to its low adverse effect profile. Hematological adverse effects related to sertraline are uncommon. This report includes a case which presented to an emergency department with a large ecchymotic lesion on the left flank due to sertraline use and a review of the relevant literature.

Özet

Sertralin düşük yan etki profili nedeniyle sık kullanılan bir antidepresandır. Sertraline bağlı hematolojik yan etkiler nadirdir. Burada sertralin kullanımı sonrasında sol sırt bölgesinde yaygın ekimotik lezyon gelişmesi üzerine acil servise başvuran olgu sunularak literatür gözden geçirilmiştir.

🔖

Cite This Article

KILIÇ, E., CİNAR, O., KESİM, M. E., AK, M., Çevik, E. (2022). Sertralin kullanımına bağlı ekimoz: Bir olgu sunumu. Klinik Psikofarmakoloji Bülteni, Cilt: 20 - Sayı: 4, 321–323. https://ajindex.com/articles/571986

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Bottlender R, Dobmeier P, Moller H. The effect of selective serotonin-reuptake inhibitors in blood coagulation. Fortschr Neurol Psychiatr. 1998;66:32-35
  2. Nelva A, Guy C, Tardy-Poncet B. Hemorrhagic syndromes related to selective serotonin reuptake inhibitor (SSRI) antidepressants. Seven case reports and review of the literature. RevMed Interne. 2000;21:152-160
  3. Yaryura-Tobias J, Kirschen H, Ninan P. Fluoxetine and bleeding in obsessive compulsive disorder. Am J Psychiatry. 1991;148:9-18
  4. Mathew T, Desmond P, Isaacs D. Bruising and bleeding with ssris. Australian Adverse Drug Reactions Bulletin. 1998;17:10-12
  5. Mirsal H, Kalyoncu A, Pektas O. Ecchymosis associated with the use of fluoxetine. Türk Psikiyatri Dergisi. 2002;13:320-324
  6. Fountoulakis K, Samolis S, Iacovides A, Kaprinis G. Ecchymoses as an adverse effect of fluoxetine treatment. Psychiatry Research. 2007;152:91-92
  7. Skop B, Brown T. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics. 1996;37:12-16
  8. Askın R, Herken H. Selektif serotonin geri alım inhibitörleri ve beklenmeyen yan etkileri Klinik Psikofarmakoloji Bülteni 1998;8(4):249-250 9. Hourani S, Cusack N: Pharmacologic receptors on blood platelets. Pharmacol Rev 1991; 43:243–298 10. Declerck F: The role of serotonin in thrombogenesis. Clinical Physiology and Biochemistry 1991; 8(suppl 3):S40–S49 11. Oyesanmi O, Kunkel E, Monti D, Field HL. Hematologic Side Effects of Psychotropics.Psychosomatics 1999; 40:414–421 12. Sarma A, Horne MK.Venlafaxine-induced ecchymoses and impaired platelet aggregation.Eur J Haematol. 2006;77:533-7
  9. Sheehan DV, Croft HA, Gossen ER, Levitt RJ, Brullé C, Bouchard S, Rozova Extended-release Trazodone in Major Depressive Disorder: A Randomized, Double-blind, Placebo-controlled Study. Psychiatry (Edgmont). 2009;6:20-33.)